Viewing Study NCT04608305


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-05-17 @ 2:47 AM
Study NCT ID: NCT04608305
Status: COMPLETED
Last Update Posted: 2023-11-18
First Post: 2020-10-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine
Sponsor: Israel Institute for Biological Research (IIBR)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module